The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Commentary Cutting cancer costs is a worthy policy, but we need to try to prevent it too April 15, 2019 Terry Slevin, Australian National University and Simone Pettigrew, Curtin University Removing the financial worries from…